Modelling clinical data shows active tissue concentration of daclatasvir is 10-fold lower than its plasma concentration.
about
A quantitative high-resolution genetic profile rapidly identifies sequence determinants of hepatitis C viral fitness and drug sensitivityRational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus InfectionDaclatasvir for the treatment of hepatitis C virus infection.The safety of daclatasvir for the treatment of hepatitis C.Integrated pharmacokinetic/viral dynamic model for daclatasvir/asunaprevir in treatment of patients with genotype 1 chronic hepatitis C.Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence
P2860
Modelling clinical data shows active tissue concentration of daclatasvir is 10-fold lower than its plasma concentration.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Modelling clinical data shows ...... than its plasma concentration.
@ast
Modelling clinical data shows ...... than its plasma concentration.
@en
type
label
Modelling clinical data shows ...... than its plasma concentration.
@ast
Modelling clinical data shows ...... than its plasma concentration.
@en
prefLabel
Modelling clinical data shows ...... than its plasma concentration.
@ast
Modelling clinical data shows ...... than its plasma concentration.
@en
P2093
P2860
P50
P356
P1476
Modelling clinical data shows ...... than its plasma concentration.
@en
P2093
C Anders Olson
Hangfei Qi
P2860
P304
P356
10.1093/JAC/DKT423
P407
P577
2013-10-29T00:00:00Z